Rapid deployment kits can facilitate tech transfer and allow for communication between operators onsite and experts offsite, despite travel bans and other limitations posed by the coronavirus (COVID-19) pandemic.
Rapid deployment kits can facilitate tech transfer and allow for communication between operators onsite and experts offsite, despite travel bans and other limitations posed by the coronavirus (COVID-19) pandemic.
Global pharmaceutical companies depend on global collaboration with suppliers, consultants, and contract partners around the world. Emergency responses to the coronavirus pandemic, including the travel ban recently enacted between the United States and the European Union, as well as facility closures and meeting bans, have made such collaboration more challenging.
To help prevent gaps in communication and training that can lead to serious supply chain disruptions and drug shortages, the augmented reality technology vendor, Apprentice.io, has sent a number of “rapid deployment kits” loaded with its hands-free Tandem technology platform to pharmaceutical R&D and manufacturing sites around the world. The kits can be customized, a company senior management says, and include smart glasses and accessories.
Apprentice.io has seen a significant number of kit requests from pharma organizations, manufacturers, suppliers, and outsourcing partners, its executives say, noting that Tandem allows in-suite operators to connect with out-of-suite subject matter experts, contract research and contract development and manufacturing organizations, and equipment vendors without requiring that those external experts travel to the site and gown up.
The technology was designed to facilitate tech transfer of methods and processes between internal and outsourced sites, eliminating the need for travel. It also allows remote acceptance testing and safe facility tours to be conducted, which can help prevent delays in newly approved drugs moving from clinical to commercial manufacturing.
Source: Apprentice.io
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.